Brain mechanisms in drug addiction—new brain pathways revealed

November 24, 2016 by Dan Wheelahan, University of New South Wales
UNSW researchers have identified two distinct brain pathways that are switched on during alcohol-related relapse. The discovery opens up a new target for developing treatments for drug and alcohol addiction. Credit: Shutterstock/University of New South Wales

UNSW researchers have identified new brain pathways linked to addiction and shown that by manipulating them, drug seeking behaviour and motivation for alcohol can be reduced.

UNSW researchers have identified new brain pathways linked to addiction and shown that by manipulating them, drug seeking behaviour and motivation for alcohol can be reduced.

While the discovery was made in rats, it opens up a new target for developing treatments for drug and in humans, which could include deep brain stimulation.

The study has been published in the Journal of Neuroscience.

Drug addiction is a chronic relapsing disorder characterised by cycles of drug abuse, abstinence and relapse.

"Current drug therapies are generally poor because we still don't completely understand how the brain's neural circuits contribute to different forms of relapse," said first author of the study, Dr Asheeta Prasad from UNSW's School of Psychology.

"Mapping these circuits is crucial if we are to move forward in treating drug and alcohol addiction," Dr Prasad said.

The researchers studied the brain's ventral pallidum (VP), which is responsible for regulating motivation, behaviour, and emotions.

Previous studies have shown that activity in the VP has been implicated in a variety of drugs of abuse including cocaine, amphetamines and alcohol. Importantly, VP is a key brain region for promoting relapse, with VP neurons activated during different forms of relapse.

The UNSW researchers identified for the first time that two distinct VP output brain pathways are necessary for different forms of alcohol-related relapse. They found that the brain pathways from the VP to the subthalamic nucleus, a small lens-shaped nucleus in the brain, and the ventral tegmental area, part of the mid-brain, are switched on during relapse behaviour. Their study has identified a novel node in the brain circuitry for

When the researchers switched off these brain pathways, drug seeking behaviour and motivation for alcohol was reduced in rats.

The finding opens up the potential for using in the treatment of addiction.

"Deep of the subthalamic nucleus is currently used to manage Parkinson's disease, but has not yet been tested in the treatment of addiction," Dr Prasad said.

"It is a certainly a potential future treatment for relapsing disorders such as and obesity."

Explore further: Scientists show molecule in brain may drive cocaine addiction

More information: A. A. Prasad et al. Ventral Pallidum Output Pathways in Context-Induced Reinstatement of Alcohol Seeking, Journal of Neuroscience (2016). DOI: 10.1523/JNEUROSCI.2580-16.2016

Related Stories

Scientists show molecule in brain may drive cocaine addiction

August 10, 2016
A new study from scientists at The Scripps Research Institute (TSRI), funded by the National Institutes of Health's (NIH) National Institute on Drug Abuse (NIDA) and National Institute on Alcohol Abuse and Alcoholism (NIAAA), ...

Cocaine changes the brain and makes relapse more common in addicts

April 28, 2015
Cocaine use causes 'profound changes' in the brain that lead to an increased risk of relapse due to stress - according to new research from the University of East Anglia.

Potential new treatment for cocaine addiction

August 31, 2016
A team of researchers led by Cardiff University has discovered a promising new drug treatment for cocaine addiction.

Scientists examine the causes and treatment of addictive behaviour

November 1, 2013
(Medical Xpress)—Addiction comes in many forms: drugs, alcohol, cigarettes, and gambling have been the types that traditionally plagued society.

Three new studies converge on promising new target for addiction treatment

September 14, 2015
The latest issue of Biological Psychiatry presents the results of three studies implicating metabotropic glutamate receptor 2 (mGluR2) as a new molecular target for the treatment of addiction.

Meds can help recovering meth addicts stay sober

June 14, 2012
(Medical Xpress) -- A drug shown to help break alcohol addiction can also help recovering methamphetamine addicts stay clean, a study led by University of Virginia School of Medicine researcher Dr. Bankole A. Johnson has ...

Recommended for you

How do we lose memory? A STEP at a time, researchers say

March 23, 2018
In mice, rats, monkeys, and people, aging can take its toll on cognitive function. A new study by researchers at Yale and Université de Montréal reveal there is a common denominator to the decline in all of these species—an ...

Brain's tiniest blood vessels trigger spinal motor neurons to develop

March 23, 2018
A new study has revealed that the human brain's tiniest blood vessels can activate genes known to trigger spinal motor neurons, prompting the neurons to grow during early development. The findings could provide insights into ...

Being hungry shuts off perception of chronic pain

March 22, 2018
Pain can be valuable. Without it, we might let our hand linger on a hot stove, for example. But longer-lasting pain, such as the inflammatory pain that can arise after injury, can be debilitating and costly, preventing us ...

From signal propagation to consciousness: New findings point to a potential connection

March 22, 2018
Researchers at New York University have discovered a novel mechanism through which information can be effectively transmitted across many areas in the brain—a finding that offers a potentially new way of understanding how ...

Using simplicity for complexity—new research sheds light on the perception of motion

March 22, 2018
A team of biologists has deciphered how neurons used in the perception of motion form in the brain of a fly —a finding that illustrates how complex neuronal circuits are constructed from simple developmental rules.

Focus on early stage of illness may be key to treating ALS, study suggests

March 22, 2018
A new kind of genetically engineered mouse and an innovation in how to monitor those mice during research have shed new light on the early development of an inherited form of amyotrophic lateral sclerosis (ALS).


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.